Bis(catechol) Ligands Derived from Tröger’s Base
1-Ethynyl-2,3-bis(methoxymethoxy)benzene (12): Compound 11
[C37H34N2O4]+. C37H34N2O4 (570.68)·1/4toluene: calcd. C 78.39, H
(400 mg, 1.36 mmol) and KF (158 mg, 2.70 mmol, 2 equiv.) were 6.11, N 4.72; found C 78.40, H 6.19, N 4.81. HRMS (EI): calcd.
dissolved in MeOH (30 mL), and the resulting solution was stirred
for 18 h at room temperature. Evaporation of the solvent yielded
the product, which was purified by column chromatography on sil-
ica gel [n-nexane/ethyl acetate (4:1) + 0.5% Et3N, Rf = 0.29] and
isolated as a colorless oil. Yield: 281 mg (1.26 mmol, 93%). 1H
NMR (500.1 MHz, CDCl3): δ = 3.26 (s, 1 H, CϵCH), 3.50 (s, 3
H, -OCH3@C-3Ph), 3.65 (s, 3 H, -OCH3@C-2Ph), 5.19 (s, 2 H,
-OCH2OCH3@C-3Ph), 5.26 (s, 2 H, -OCH2OCH3@C-2Ph), 6.99
(dd, J = 7.7 Hz, J = 8.2 Hz, 1 H, 5-H), 7.13–7.16 (m, 2 H, 4-H,
6-H) ppm. 13C NMR (125.8 MHz, CDCl3): δ = 56.2 (-OCH3@C-
3Ph), 57.5 (-OCH3@C-2Ph), 80.0 (CϵCH), 81.2 (CϵCH), 95.3
(-OCH2OCH3@C-3Ph), 98.8 (-OCH2OCH3@C-2Ph), 117.6 (C-1),
117.8 (C-4), 124.2 (C-5), 127.2 (C-6), 148.4 (C-2), 150.2 (C-3) ppm.
MS (EI): m/z (%) = 222.1 (100) [C12H14O4]+. C12H14O4 (222.24)·
1/3CH2Cl2: calcd. C 59.12, H 5.90; found C 58.78, H 5.88. HRMS
(EI): calcd. for C12H14O4 222.0892; found 222.0887.
for C37H34N2O4 570.2519; found 570.2521.
2,8-Bis[2,3-bis(methoxymethoxy)benzene-1-ylethynyl]-4,10-dimeth-
yl-6H,12H-5,11-methanodibenzodiazocine (13): THF (7 mL) and di-
isopropylamine (85 mg, 0.84 mmol, 3 equiv.) were added to 7
(141 mg, 0.28 mmol), CuI (2 mg, 11 ϫ 10–3 mmol, 4 mol-%),
[Pd2(dba)3·CHCl3] (9 mg, 17 ϫ 10–3 mmol, 6 mol-% Pd), dppf
(9.3 mg, 17ϫ10–3 mmol, 6 mol-%), and 12 (150 mg, 0.67 mmol,
2.4 equiv.). The resulting mixture was stirred at 60 °C for 16 h. Sat-
urated aqueous NaCl and dichloromethane were added, and the
mixture was filtered through Celite. The residue was washed with
dichloromethane. The filtrate was washed with saturated aqueous
NaHCO3, and the organic layer was dried with Na2SO4. The prod-
uct was purified by column chromatography on silica gel [toluene/
THF (9:1) + 5% Et3N, Rf = 0.56] and obtained as a yellow solid.
Yield: 148 mg (0.21 mmol, 76 %). M.p. 202–204 °C. 1H NMR
(500.1 MHz, CDCl3): δ = 2.40 (s, 6 H, -CH3), 3.50 (s, 6 H,
-OCH3@C-3Ph), 3.65 (s, 6 H, -OCH3@C-2Ph), 3.98 (d, 2J =
3
3
Synthesis of the Derivatives of Tröger’s Base
2
–17.0 Hz, 2 H, 6endo-H, 12endo-H), 4.02 (s, 2 H, 13-H), 4.58 (d, J
2,8-Diiodo-4,10-dimethyl-6H,12H-5,11-methanodibenzodiazocine
(7): 4-Iodo-2-methylaniline (7.5 g, 32.02 mmol) and paraformalde-
hyde (2.02 g, 67.25 mmol, 2.1 equiv.) were dissolved in trifluoro-
acetic acid (64 mL, 0.80 mol, 26 equiv.), which resulted in a dark-
purple-colored reaction mixture. The mixture was stirred for 16 h
and poured into H2O (200 mL) to yield a brown precipitate. Aque-
ous NaOH (6 ) was added to this suspension (pH 9), the precipi-
tate was filtered off, and recrystallized from acetone, and the solu-
tion was stored at –20 °C for 12 h. A first product fraction was
obtained by collecting the precipitate. A second crop could be iso-
lated by concentrating the mother liquor and purification of the
crude product by column chromatography on silica gel (toluene +
0.5% Et3N, Rf = 0.25). Yield: 6.03 g (12.01 mmol, 75%; 55% after
recrystallization and the remaining 20% by column chromatog-
raphy). Analytical data were in accordance with those previously
published.[25]
= –17.0 Hz, 2 H, 6exo-H, 12exo-H), 5.20 (s, 4 H, -OCH2OCH3@C-
3
Ph), 5.27 (s, 4 H, -OCH2OCH3@C-2Ph), 6.97 (s, 2 H, 1-H, 7-H),
6.99 (d, 3J = 7.7 Hz, 2 H, 5Ph-H, 5ЈPh-H), 7.11 (dd, 3J = 7.7 Hz, J
= 1.1 Hz, 4 H, 4Ph-H, 4ЈPh-H, 6Ph-H, 6ЈPh-H), 7.23 (s, 2 H, 3-H, 9-
H) ppm. 13C NMR (125.8 MHz, CDCl3): δ = 17.0 (-CH3), 54.8 (C-
6, C-12), 56.2 (-OCH3@C-3Ph), 57.5 (-OCH3@C-2Ph), 67.4 (C-13),
85.0 (CϵC-Ph), 93.3 (CϵC-Ph), 95.3 (-OCH2OCH3@C-3Ph), 98.7
(-OCH2OCH3@C-2Ph), 117.1 (C-6Ph, C-6ЈPh), 118.5 (C-2, C-8),
118.8 (C-1Ph, C-1ЈPh), 124.2 (C-5Ph, C-5ЈPh), 126.7 (C-4Ph, C-4ЈPh),
127.6 (C-1, C-7), 128.1 (C-14, C-16), 132.1 (C-3, C-9), 133.1 (C-4,
C-10), 146.4 (C-15, C-17), 147.7 (C-2Ph, C-2ЈPh), 150.2 (C-3Ph, C-
3Ph) ppm. MS (EI): m/z (%) = 690.3 (100) [C41H42N2O8]+.
C41H42N2O8 (690.78)·H2O: calcd. C 69.48, H 6.26, N 3.95; found
C 69.42, H 6.20, N 3.93. HRMS (EI): calcd. for C41H42N2O8
690.2941; found 690.2937.
4
2,8-Bis(2,3-dihydroxybenzene-1-ylethynyl)-4,10-dimethyl-6H,12H-
5,11-methanodibenzodiazocine (1): Compound 13 (340 mg,
0.49 mmol) was dissolved in MeOH (10 mL) and THF (10 mL).
Concentrated hydrochloric acid (2 mL) was added to this solution,
which was then stirred for 24 h at room temperature. The solvents
were evaporated, and the crude product was dissolved in ethyl ace-
tate. After the addition of H2O, the layers were separated, and the
aqueous phase was extracted with ethyl acetate (3ϫ). The com-
bined organic layers were dried with Na2SO4, and the product was
dried in vacuo. Yield: 226 mg (0.44 mmol, 90%). M.p. Ͼ250 °C. 1H
NMR (500.1 MHz, [D6]DMSO): δ = 2.38 (s, 6 H, -CH3), 4.12 (d,
2J = –17.0 Hz, 2 H, 6endo-H, 12endo-H), 4.38 (s, 2 H, 13-H), 4.57 (d,
2,8-Bis(2,3-dimethoxybenzene-1-ylethynyl)-4,10-dimethyl-6H,12H-
5,11-methanodibenzodiazocine (8): THF (10 mL) and diisopropyl-
amine (145 mg, 1.43 mmol, 2.4 equiv.) were added to a mixture of
7 (300 mg, 0.70 mmol), CuI (4.6 mg, 24ϫ10–3 mmol, 4 mol-%),
[Pd2(dba)3·CHCl3] (19 mg, 36 ϫ 10–3 mmol, 6 mol-% Pd), dppf
(20 mg, 36 ϫ 10–3 mmol, 6 mol-%), and 6 (214 mg, 1.31 mmol,
2.2 equiv.). The resulting mixture was stirred at 60 °C for 18 h. Sat-
urated aqueous NaCl and dichloromethane were added, and the
mixture was filtered through Celite. The residue was washed with
dichloromethane. The filtrate was washed with saturated aqueous
NaHCO3, and the organic layer was dried with Na2SO4. The prod-
uct was purified by column chromatography on silica gel [toluene/
THF (9:1) + 5% Et3N, Rf = 0.50] and obtained as a colorless solid.
Yield: 260 mg (0.46 mmol, 75 %). M.p. 179–181 °C. 1H NMR
(500.1 MHz, CDCl3): δ = 2.42 (s, 6 H, -CH3), 3.86 (s, 6 H,
-OCH3@C-3Ph), 3.95 (s, 6 H, -OCH3@C-2Ph), 4.02 (d, 2J =
3
3
2J = –17.0 Hz, 2 H, 6exo-H, 12exo-H), 6.60 (dd, J = 7.7 Hz, J =
7.7 Hz, 2 H, 5Ph-H, 5ЈPh-H), 6.77–6.78 (m, 4 H, 4Ph-H, 4ЈPh-H, 6Ph
-
H, 6ЈPh-H), 7.05 (s, 2 H, 1-H, 7-H), 7.24 (s, 2 H, 3-H, 9-H), 8.85
(br. s, 2 H, OH), 9.46 (br. s, 2 H, OH) ppm. 13C NMR (125.8 MHz,
[D6]DMSO): δ = 16.6 (-CH3), 54.0 (C-6, C-12), 67.0 (C-13), 86.1
(CϵC-Ph), 92.2 (CϵC-Ph), 110.4 (C-1Ph, C-1ЈPh), 115.9 (C-4Ph, C-
4ЈPh), 118.4 (C-2, C-8), 119.2 (C-5Ph, C-5ЈPh), 122.9 (C-6Ph, C-6ЈPh),
127.6 (C-1, C-7), 128.3 (C-14, C-16), 131.5 (C-3, C-9), 132.9 (C-4,
C-10), 144.9 (C-15, C-17), 145.5 (C-3Ph, C-3ЈPh), 152.7 (C-2Ph, C-
2ЈPh) ppm. MS (EI): m/z (%) = 514.2 (100) [C33H26N2O4]+.
C33H26N2O4 (514.57)·7/2H2O: calcd. C 68.62, H 5.76, N 4.85;
found C 68.49, H 5.56, N 4.50. HRMS (EI): calcd. for C33H26N2O4
514.1892; found 514.1894.
2
–17.0 Hz, 2 H, 6endo-H, 12endo-H), 4.37 (s, 2 H, 13-H), 4.62 (d, J
= –17.0 Hz, 2 H, 6exo-H, 12exo-H), 6.88 (s, 3J = 7.8 Hz, 4J = 1.6 Hz,
2 H, 4Ph-H,4ЈPh-H), 6.97–7.00 (m, 4 H, 1-H, 7-H, 5Ph-H, 5ЈPh-H),
3
4
7.03 (dd, J = 7.8 Hz, J = 1.6 Hz, 2 H, 6Ph-H, 6ЈPh-H), 7.26 (s, 2
H, 3-H, 9-H) ppm. 13C NMR (125.8 MHz, CDCl3): δ = 17.0
(-CH3), 54.8 (C-6, C-12), 56.0 (-OCH3@C-3Ph), 61.0 (-OCH3@C-
2Ph), 67.6 (C-13), 84.8 (CϵC-Ph), 93.2 (CϵC-Ph), 112.8 (C-4Ph, C-
4ЈPh), 118.1 (C-1Ph, C-1ЈPh), 118.7 (C-2, C-8), 123.8 (C-5Ph, C-5ЈPh),
125.0 (C-6Ph, C-6ЈPh), 127.8 (C-1, C-7), 128.0 (C-14, C-16), 132.1
(C-3, C-9), 133.0 (C-4, C-10), 146.2 (C-15, C-17), 150.3 (C-3Ph, C- 2,8-Bis(2,3-dihydroxybenzenemethanimine)-4,10-dimethyl-6H,12H-
3ЈPh), 152.7 (C-2Ph, C-2ЈPh) ppm. MS (EI): m/z (%) = 570.3 (100) 5,11-methanodibenzodiazocine (2): Compound 14 (250 mg,
Eur. J. Org. Chem. 2007, 5703–5711
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5709